EP3740244
ADENO-ASSOCIATED VIRUS GENE THERAPY FOR 21-HYDROXYLASE DEFICIENCY
:
EP einkaleyfi: EP einkaleyfi tilnefnt til gildistöku á Íslandi:
17.1.2019:
21.5.2025:
19706059.3
:
16.1.2039:
16.1.2026
:
ADENO-ASSOCIATED VIRUS GENE THERAPY FOR 21-HYDROXYLASE DEFICIENCY
17.1.2019
21.5.2025
16.1.2026
:
Adrenas Therapeutics, Inc.:
421 Kipling Street, Palo Alto CA 94301, US
:
BOUGNERES, Pierre:
Palo Alto, California 94301, US
:
GAO, Guangping:
Palo Alto, California 94301, US
:
201862618307 P:
17.1.2018:
US
:
201862640311 P:
8.3.2018:
US
:
US2019013991:
17.1.2019
:
A61K 48/00, C12N 15/86, C12N 9/02